TMC Life Sciences BhdXKLS:0101 62 Days Payable is 171.35 as of Mar. 2026, which is 9% above its 10-year median of 156.83. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks better than 79.41% on this metric.
The historical rank and industry rank for TMC Life Sciences Bhd's Days Payable or its related term are showing as below:
XKLS:0101'
s Days Payable Range Over the Past 10 Years
Min: 69.07 Med: 156.83 Max: 299.27
Current: 147.46
During the past 13 years, TMC Life Sciences Bhd's highest Days Payable was 299.27. The lowest was 69.07. And the median was 156.83.
XKLS:0101's Days Payable is ranked better than 79.41% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs XKLS:0101: 147.46
TMC Life Sciences Bhd Days Payable Historical Data
* Premium members only.
The historical data trend for TMC Life Sciences Bhd's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0101 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Days Payable distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
TMC Life Sciences Bhd's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMC Life Sciences Bhd (XKLS:0101) has a Days Payable of 171.35 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TMC Life Sciences Bhd and its competitors. This is near median its historical median of 156.83. Over the past decade, TMC Life Sciences Bhd's Days Payable has ranged from 69.07 to 299.27. According to the industry distribution chart, TMC Life Sciences Bhd ranks #125 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is TMC Life Sciences Bhd's Days Payable too high?
TMC Life Sciences Bhd's current Days Payable of 171.35 is near median its 10-year median of 156.83. Over the past 10 years, this metric has ranged from a low of 69.07 to a high of 299.27. The Healthcare Providers & Services industry median Days Payable is 58.00. TMC Life Sciences Bhd's value of 171.35 is 195.4% above this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #125 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #125 out of 607 companies for Days Payable. This places TMC Life Sciences Bhd in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.00. TMC Life Sciences Bhd's value of 171.35 is 195.4% above this benchmark. Historically, TMC Life Sciences Bhd's own Days Payable has ranged from 69.07 to 299.27 over the past decade. While the company's 10-year median is 156.83 vs. the industry median of 58.00, TMC Life Sciences Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current Days Payable of 171.35 is 195.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current Days Payable is 171.35, which is near median its own 10-year median of 156.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.45 — trading 27.4% below its estimated fair value. The current Days Payable is 171.35, which is near median its 10-year median of 156.83 and 195.4% above the Healthcare Providers & Services industry median of 58.00. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Days Payable is 171.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.45 is trading 27.4% below its estimated GF Value™ of RM0.62.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
Days Payable: 171.35 (near median its 10-year median of 156.83)
GF Value™: RM0.62 vs. price of RM0.45 (27.4% below fair value)
Industry Position: 195.4% above the Healthcare Providers & Services median (#125 of 607)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score
Get the complete analysis for XKLS:0101
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
